Cookies Policy
X

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

I accept this policy

Find out more here

Urinary 5-hydroxyindoleacetic acid excretion and kaolin ingestion after a single administration of cisplatin in the delayed emesis rat model

No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.

Brill’s MyBook program is exclusively available on BrillOnline Books and Journals. Students and scholars affiliated with an institution that has purchased a Brill E-Book on the BrillOnline platform automatically have access to the MyBook option for the title(s) acquired by the Library. Brill MyBook is a print-on-demand paperback copy which is sold at a favorably uniform low price.

This Article is currently unavailable for purchase.
Add to Favorites
You must be logged in to use this functionality

In this study, rat kaolin ingestion (pica) and serial urinary 5-hydroxyindoleacetic acid (5-HIAA) excretions were determined for three days after a single administration of low-dose cisplatin (5 mg/kg, intraperitoneal, i.p.). We found that cisplatin induced acute (first 24 hours after chemotherapy) and delayed phases (24-72 hours after chemotherapy) of kaolin ingestion in rats. An increase in urinary 5-HIAA excretion was also observed in the cisplatin-administered group. These results suggest that 5-HT is involved in delayed emesis, and that urinary 5-HIAA excretion can be used as a marker in the study of delayed emesis.

10.1163/15693910260698249
/content/journals/10.1163/15693910260698249
dcterms_title,pub_keyword,dcterms_description,pub_author
10
5
Loading
Loading

Full text loading...

/content/journals/10.1163/15693910260698249
Loading

Data & Media loading...

http://brill.metastore.ingenta.com/content/journals/10.1163/15693910260698249
Loading

Article metrics loading...

/content/journals/10.1163/15693910260698249
2017-08-23

Sign-in

Can't access your account?
  • Key

  • Full access
  • Open Access
  • Partial/No accessInformation